Linden Advisors’s Translational Development Acquisition Corp Units TDACU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-600,000
Closed -$6.02M 328
2024
Q4
$6.02M Buy
+600,000
New +$6.01M 0.05% 153

Other funds holding TDACU

Linden Advisors's TDACU Position: Q1 2025 in Review

Linden Advisors sold out of Translational Development Acquisition Corp Units (TDACU) in Q1 2025, closing a stake of 600,000 shares — an estimated $6.02M sold.

Linden Advisors first reported a position in TDACU in Q4 2024 and held it in 1 quarter. The position peaked at $6.02M in Q4 2024. 21 funds tracked by Wall St. Rank hold TDACU as of Q1 2025.

  • Linden Advisors reported no remaining Translational Development Acquisition Corp Units position as of Q1 2025 after selling out during the quarter.
  • Linden Advisors sold 600,000 Translational Development Acquisition Corp Units shares in Q1 2025, an estimated $6.02M.
  • Linden Advisors first reported a position in Translational Development Acquisition Corp Units in Q4 2024 and held it in 1 quarter.
  • Linden Advisors's Translational Development Acquisition Corp Units position peaked at $6.02M in Q4 2024.
  • 21 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Units as of Q1 2025.

Based on Linden Advisors's 13F filing for Q1 2025, filed 15 May 2025.